Mandate

Vinge advises the Swedish Olympic Committee (SOC) in a high-profile and fundamentally important arbitral award by the Court of Arbitration for Sport (CAS)

February 28, 2025 Dispute Resolution

Vinge has advised the SOC in a highly publicised and fundamentally important arbitration concerning the selection process for the Paris Olympics. In the case, CAS ruled that the SOC’s selection rules for the Olympic Games are fully permissible.

Days before the opening ceremony of the Olympic Games in Paris, an urgent arbitration was decided in the Court of Arbitration for Sport, CAS, in which a number of athletes appealed the decision of SOC not to select them for the Paris Olympics.

Following an expedited arbitration, CAS ruled in favour of the SOC on 26 July 2024, the same day as the opening of the Olympic Games, but without providing any reasons for its decision.

CAS has now announced its reasons for the award. In a landmark ruling for the international sports movement, CAS now states that National Olympic Committees may apply their own, stricter selection criteria than the international qualification limits and rules set by international sports federations (e.g. World Aquatics, World Athletics, etc.), which was the main issue in the proceedings.

CAS thus confirms that the selection rules applied by SOC for the Paris Games are in accordance with The Olympic Charter, the highest legal authority of the Olympic Games. The SOC has issued the following press release.

CAS is an international body based in Switzerland that deals with disputes in sport, including player transfers, sponsorship contracts, doping and other disciplinary issues.

Vinge has worked with the SOC since 2016, and in 2020 entered into a long-term partnership with the Swedish Paralympic Committee (SPC) as official business legal adviser, read more here.

Vinge’s team in the CAS dispute consisted of James Hope, Nils Ivars and Sebastian Saadieh

Related

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026

Vinge has advised Resurs in connection with its strategic partnership with Kustom

Vinge has advised Resurs in connection with its strategic partnership with Kustom (formerly Klarna Checkout), a fast-growing player in the digital commerce sector. The partnership enables Resurs to accelerate its strategic development by offering a check-out solution to its merchants, built on Kustom’s market-leading infrastructure.
March 25, 2026

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of MedMera Bank AB

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of all shares in MedMera Bank AB from Kooperativa Förbundet for a total consideration of SEK 1,960 million. The transaction positions Morrow Bank as a leading Nordic platform in consumer finance with combined gross loans of SEK 28.2 billion.
March 24, 2026